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Abstract
Background
The Malaria Vaccine Implementation Program, coordinated by the World Health Organiza-
tion, intended to initiate the roll-out of the RTS, S/AS01 malaria vaccine in 3 sub-Saharan
African countries in 2018. With sub-optimal implementation, the effectiveness of this vaccine
in routine clinical use could be significantly lower than its measured efficacy in randomized
trials. This study had as objectives to systematically review and summarize published stud-
ies addressing the challenges faced during the implementation phase of malaria vaccination
programs and randomized trials conducted in sub-Saharan Africa. The review also sought
to report proposed solutions to the challenges identified.
Method
This was a systematic review of studies published between 1947 and 2017. Medline,
Embase and the Cochrane library databases were searched. Of the 365 studies retrieved, 8
eligible studies reported on challenges of implementing a malaria vaccine in sub-Saharan
Africa and possible solutions to these challenges. Data were abstracted from the eligible
studies and a qualitative synthesis was done.
Results
The 8 studies included in the review had a total of 6189 participants and used a variety of
methodologies (3 qualitative, 1 quantitative, 3 mixed method studies and 1 clinical trial
review). There was an overall positive acceptance towards the new malaria vaccine (n = 6/8
studies), with a mean acceptance rate of 86.1% (95% CI: 62.0–110.2, n = 2). The main chal-
lenges to vaccine receptivity were: inadequate community engagement due to lack of infor-
mation about the vaccine (n = 6), fear of the vaccine’s side effects (n = 5), inefficient delivery
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of vaccination services to children (n = 4), and sub-optimal quality of the health services (n =
3). Main themes identified from the proposed solutions consisted of the following: using
dynamic communication models and trusted sources for delivering vaccine-related health
information to the communities (n = 6), community engagement at both national and district
level (n = 6), implementing the new vaccine services alongside the existing health services
already delivered (n = 6).
Conclusion/Recommendations
Effective implementation of the malaria vaccine program requires careful consideration of
the socio-cultural context of each community. The RTS, S/AS01 malaria vaccine accep-
tance and uptake may be significantly enhanced if caregivers’ perceptions about vaccines
and their importance are adequately fine-tuned. In order to achieve these, community partic-
ipation and the provision of adequate information in an acceptable form via reliable commu-
nication channels seem to be imperative.
Introduction
Significant progress has been made worldwide in controlling malaria over the past decades, with a
reported 62% reduction in malaria-related mortality between 2000 and 2015 [1]. Despite these
achievements, malaria remains a major public health concern. In 2015, it was estimated that there
were 212 million cases of malaria and 429,000 malaria-related deaths worldwide, with sub-Saha-
ran Africa (SSA) bearing the greatest burden [1]. Current malaria prevention measures in SSA
include chemoprevention in pregnant women and infants, vector control using insecticide treated
bed nets and indoor residual spraying. Despite these measures, malaria remains a major cause of
mortality in this part of the world especially among children under five years of age.
Several malaria vaccine projects have been underway in a bid to address the huge burden
posed by malaria. In 2015, the European Medicines Agency for the immunization of children
against malaria approved the RTS, S/AS01 vaccine [2]. This is currently the most clinically
advanced malaria vaccine [2]. Phase 3 clinical trials conducted in various sites in Africa showed
that the RTS, S/AS01 vaccine has a protective efficacy of 45% in children in the first twenty
months after vaccination [3,4]. In 2018, the World Health Organization through a large scale
pilot malaria vaccine implementation program (MVIP) aimed to introduce this vaccine in three
sub-Saharan countries (Ghana, Kenya, Malawi) [5]. However, the effectiveness of this vaccine
in routine clinical use might be much lower than in randomized trials because of the effect of
external factors such as vaccine receptivity, storage and administration. Optimal implementa-
tion of the vaccine program is therefore required to ensure maximum efficacy. To achieve this,
it is important to investigate potential challenges during the implementation phase of the vacci-
nation programs and take the appropriate measures to address these challenges. This study
aimed to review existing evidence on the challenges to the implementation of earlier malaria
vaccination programs in SSA and to explore proposed solutions to these challenges.
Methods
Search strategy and selection criteria
This was a systematic review of studies on the implementation of malaria vaccine programs
and randomized trials in SSA. The studies reviewed were published between January 1947 and
December 2017. Databases searched included: Cochrane library, Embase and Medline. An
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extensive search strategy was developed by combining the subject heading search and the key-
words free-text search (Table 1). Articles retrieved from the search were saved on the Zotero
referencing manager (version 4.0.29.22). The reference lists of appropriate studies were also
reviewed to identify additional studies. The titles and abstracts of all identified studies were
then screened by 2 independent investigators (CAD and BTK). Following the titles and
abstracts screening, the full texts of retained studies were independently reviewed by both
investigators to identify eligible studies.
The studies included were:
• Those published in English between January 1947 (earliest date of databases) and June 2017.
• Quantitative and qualitative studies and reviews with data on the challenges to the imple-
mentation of malaria vaccination interventions in SSA and the proposed solutions.
• Interventional studies, observational studies and reviews.
Studies excluded were:
• Those with insufficient data on the challenges or solutions to the implementation of malaria
vaccine projects in SSA.
• Conference abstracts, reports and bulletins.
Data analysis and synthesis
Data was extracted from eligible studies by the principal investigator (CAD). The extracted
data was saved on a Microsoft Excel 2016 form and subsequently double-checked for accuracy
Table 1. Search strategy.
Search
#
Search words
1 RTS, S [Mesh]
2 RTS vaccine OR RTS,S vaccination OR RTS,S implementation OR RTS,S vaccination program� OR RTS,
S immunization OR RTS,S immunization OR RTS,S immunisation program� OR RTS,S immunization
program� OR Malaria vaccine OR Malaria vaccination OR Malaria implementation OR Malaria
vaccination program� OR Malaria immunization OR Malaria immunization OR Malaria immunisation
program� OR Malaria immunization program�
3 #1 OR #2
4 Challenges OR difficulties OR shortcomings OR problems OR complication OR drawback OR hindrance
OR impediment OR barrier OR disadvantage OR obstacle
5 Sub-Saharan Africa [MeSH]
6 Africa OR Algeria OR Angola OR Benin OR Botswana OR Burkina Faso OR Burundi OR Cameroon OR
Canary Islands OR Cape Verde OR Central African Republic OR Chad OR Comoros OR Congo OR
Democratic Republic of Congo OR Djibouti OR Egypt OR Equatorial Guinea OR Eritrea OR Ethiopia
OR Gabon OR Gambia OR Ghana OR Guinea OR Guinea Bissau OR Ivory Coast OR Cote dIvoire OR
Jamahiriya OR Jamahiryia OR Kenya OR Lesotho OR Liberia OR Libya OR Libia OR Madagascar OR
Malawi OR Mali OR Mauritania OR Mauritius OR Mayotte OR Morocco OR Mozambique OR
Mocambique OR Namibia OR Niger OR Nigeria OR Principe OR Reunion OR Rwanda OR Sao Tome
OR Senegal OR Seychelles OR Sierra Leone OR Somalia OR South Africa OR St Helena OR Sudan OR
Swaziland OR Tanzania OR Togo OR Tunisia OR Uganda OR Western Sahara OR Zaire OR Zambia OR
Zimbabwe OR Central Africa OR Central African OR West Africa OR West African OR Western Africa
OR Western African OR East Africa OR East African OR Eastern Africa OR Eastern African OR North
Africa OR North African OR Northern Africa OR Northern African OR South African OR Southern
Africa OR Southern African OR subSaharan Africa OR subSaharan African OR sub-Saharan Africa OR
sub-Saharan African
7 #5 OR #6
8 #3 AND #4 AND #7
https://doi.org/10.1371/journal.pone.0209744.t001
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by a second investigator (BTK). Data extracted consisted of: First author name, publication
year, journal reference, country and place of the study, year of study, study setting and design,
sample size, study population, vaccine acceptance rates, study limitations, reported challenges
to program implementation and proposed solutions to the challenges. The two principal out-
comes of interest were: challenges encountered, and proposed solutions. A thematic content
analysis approach was adopted for data analysis and synthesis. CAD and BTK developed the
initial coding framework on Microsoft Excel 2016 by reading through the eligible studies and
identifying main themes from these studies. The main themes were developed based on the
two main outcomes of interest: challenges to the implementation of malaria vaccination pro-
grams and proposed solutions. The coding framework was then progressively amended to
incorporate more main themes and sub-themes that emerged as each eligible study was
reviewed. The overall vaccine acceptance rate was calculated as the mean of the acceptance
rates reported by the individual studies. The quality of qualitative studies was assessed using
the critical appraisal skills program (CASP) checklist [6], while that of the interventional and
observational studies was assessed using their respective quality assessment tools as per the
National Health Institute (National Heart, Lung, and Blood Institute) [7]. Overall study quality
was rated as either good, fair or poor. A narrative approach was used to summarize the
abstracted data. This review was reported in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-Analysis (PRISMA) 2009 guidelines (See S1 Checklist for
more details). A protocol of this review is available in PROSPERO (CRD42017077479).
Results
Overview of search results and quality of studies
The search strategy returned a total of 365 studies (Fig 1). Twenty-seven studies were retained
for full text review after removal of duplicates, review of the reference list of relevant studies to
identify eligible studies, and screening of study titles and abstracts. Eight studies were eligible
for inclusion in the synthesis and had a total of 6189 participants. The main study characteris-
tics are summarized on Table 2 (See S1 Table for more details). Three of these 8 studies had an
exclusively qualitative design involving in-depth interviews, focus group discussions, semi-
structured observations and exit interviews [8–10]. One study was exclusively observational,
involving exit interviews [11]. Three of the eight studies used mixed methods: one combined a
randomized trial with a qualitative design [12] and two combined cross-sectional and qualita-
tive designs [13,14]. One of the eight studies was a clinical trial review [15]. Half of the studies
were carried out in East Africa, three were from West Africa and one was from Southern
Africa. Five of the studies were from both rural and urban settings [9–12,14] and two were
exclusively from rural settings [8,13]. Of the 6189 participants, 1157 were involved in the quali-
tative studies. These included parents, caregivers, health professionals, community leaders,
teachers, religious leaders, and other key stakeholders.
Among the studies with a qualitative component, four were of good quality [8,9,12,14] and
two were of fair quality [10,13] (S2 Table). The single randomized trial was of good quality
[12] (S3 Table). Regarding studies with observational designs, two were of good quality [13,14]
and one was of fair quality [11] (S4 Table).
Malaria vaccine acceptance
Six studies reported an overall positive acceptance to the introduction of the malaria vaccine
from the study participants [8–11,13,14]. Only two of these six studies reported numeric vac-
cine acceptance rates of 84.2% [14] and 88% [11] respectively, giving a mean vaccine accep-
tance rate of 86.1% (95% CI: 62.0–110.2, n = 2).
Challenges and solutions to the effective implementation of the RTS, S/AS01 malaria vaccine
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Challenges to vaccine receptivity
Up to 75% of the studies (n = 6/8 studies) reported inadequate community engagement result-
ing from the lack of information about the vaccine [8–12,14]. With regards to knowledge
about the malaria vaccine, a study found that up to 90% of its participants were aware that
malaria can be prevented through vaccination [13], while another study reported that 90% of
participants in its quantitative component were aware that vaccination is beneficial [14].
Fear of the vaccine’s side effects was reported as a challenge by 62.5% of the studies (n = 5)
[8–11,14].
Fig 1. PRISMA flow chart illustrating study identification and selection.
https://doi.org/10.1371/journal.pone.0209744.g001
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Half of the studies (n = 4) reported the inefficient delivery of the child immunization ser-
vices as a major barrier to adequate vaccine implementation [8–10,15]. Inefficient delivery was
linked to significant distances to vaccination sites [8,10,15], long queues and long hours of ser-
vice at the vaccination sites [8,10].
An overall low quality of the services provided in the health facility was reported in 37.5%
of the studies (n = 3) [8,10,11]. This low quality was linked to the lack of health supplies at hos-
pitals, unresponsive hospital staff, and the poor communication between hospital staff and
patients.
The vaccine acceptance was also found to be significantly affected by the health decision-
maker in the household and the decision maker’s relationship with the child to be vaccinated
[8,10,11].
Other important challenges reported by single studies were: the reduction in attendance of
clinics after nine months [9], the partiality of the protection provided by the vaccine [8], the
difficulties with storage of the vaccines [15], as well as socio-cultural practices and religious
denominations against vaccination [10]. Table 3 summarizes the challenges to vaccine recep-
tivity identified from the eligible studies.
Proposed solutions to the challenges reported
Solutions proposed to the problem of community engagement and lack of information on the
vaccine included the use of trusted sources for delivering health information, involving stake-
holders in planning and vaccine implementation at both the national and district levels, trans-
lating information about the vaccine into local languages, and involving local leadership in the
selection and design of communication messages [8,9]. Other potential solutions highlighted
in two studies were to address socio-cultural aspects (religion, ethnicity, occupation and
region) that influence the decision of parents and caregivers and to use proper communication
strategies to clarify the expectations of stakeholders prior to the introduction of the malaria
vaccine [10,14]. Other strategies proposed were to target specific segments of child caregivers
(residents of regions with low acceptance, service providers in health facilities, older caregivers,
less educated) with relevant messages [11], and to embed community engagement activities in
already existing structures and activities [12]. Implementing the malaria vaccine alongside the
package of services of already well-established programs was proposed as a solution to increase
vaccine uptake [9]. With regards to concerns about the vaccine’s side effects, effective commu-
nication on health information about the vaccine was suggested [8,9].
Providing vaccines free of charge at the clinics alongside other incentives such as bed nets
was suggested as a solution to increase vaccine uptake despite the suboptimal quality of care
Table 2. Study characteristics.
First author (publication year) Country Study year Study Design Participants
Afolabi (2014) [15] Gambia 2013 Clinical trial review 136
Angwenyi (2014) [12] Kenya 2009–2011 RCT/Qualitative 561
Bingham (2012) [8] Mozambique 2010 Qualitative 200
Febir (2013) [13] Ghana 2007 Cross-sectional/Qualitative 625
Meñaca (2014) [9] Ghana 2012–2013 Qualitative 286
Mtenga (2016) [14] Tanzania 2013 Cross-sectional/Qualitative 2144
Ojakaa (2011) [10] Kenya 2009 Qualitative 234
Ojakaa (2014) [11] Kenya 2010 Cross-sectional 2003
RCT-Randomised controlled trial
https://doi.org/10.1371/journal.pone.0209744.t002
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delivered at health facilities [10]. Solutions to the challenges reported are summarized on
Table 4. Other generic solutions proposed to the individual challenges mentioned were the
development of cold-chain free vaccines for resource-constrained settings and the develop-
ment of a sustainable “in-house” dry ice production for vaccine storage during transportation
to the vaccination services [15].
Discussion
This study is the first to assess a broad array of potential challenges to the implementation of
malaria vaccine programs in SSA. The study also examines a wide range of solutions to the
observed challenges. Moreover, the findings of this study are relevant to the MVIP, tasked
with implementing the RTS, S/AS01 vaccine in 3 sub-Saharan African countries. These find-
ings were obtained via a systematic review of published studies. In all, 8 studies (with a total of
6189 participants) were retained for the review. We noted an overall positive acceptance of a
malaria vaccine. Inadequate community engagement, lack of information on the vaccine, con-
cerns regarding the vaccine’s side effects, and inefficient delivery of the vaccination services
were identified as the major challenges to vaccine acceptance. Improved community participa-
tion and delivery of health information through trusted communication channels were pro-
posed as potential solutions.
According to the health belief model, individuals’ perceptions of diseases and beneficial
effects of interventions that serve to counter diseases are key determinants of people’s
responses to health interventions [16]. Previous studies conducted in diverse sub-Saharan
African settings found that malaria was generally perceived as a major public health problem
[17]. Therefore, it could be inferred that vaccination against malaria is perceived as an impor-
tant preventive measure by the sub-Saharan African population and this could explain the
overall high acceptance rate noted in our review.
Table 3. Identified themes regarding challenges to vaccine receptivity.
Challenge Studies Authors (publication year)
Inadequate community engagement
Lack of information on vaccine 7 Bingham (2012) [8], Meñaca (2014) [9], Mtenga (2016)
[14], Ojakaa (2011) [10], Ojakaa (2014) [11], Angwenyi
(2014) [12], Febir (2013) [13]
Fear of vaccine side effects
General fear that vaccines or injections might
harm the child
5 Bingham (2012) [8], Meñaca (2014) [9], Mtenga (2016)
[14], Ojakaa (2011) [10], Ojakaa (2014) [11]
Inefficient delivery of the child immunization services
Significant distance to vaccination services, the
long queues, and the hours of services
4 Bingham (2012) [8], Meñaca (2014) [9], Ojakaa (2011)
[10], Afolabi (2014) [15]
Quality of overall health service at health facility
Lack of health supplies,
unresponsive hospital staff,
poor communication between hospital staff
and patients
3 Bingham (2012) [8], Ojakaa (2011) [10], Ojakaa (2014)
[11]
Health decision-making in households
Relationship of the caregiver to the children 3 Bingham (2012) [8], Ojakaa (2011) [10], Ojakaa (2014)
[11]
Other reasons
Reduced clinic attendance after 9 months
Partiality of the vaccine protection Difficulties
with vaccine storage
Traditional cultural practices
4 Bingham (2012) [8], Meñaca (2014) [9], Afolabi (2014)
[15], Ojakaa (2011) [10]
https://doi.org/10.1371/journal.pone.0209744.t003
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Inadequate community engagement emerged as the most reported challenge. In recent
years, the role of community engagement as a fundamental component in the implementation
of contemporary clinical research and community-based interventions has been increasingly
recognized [18–21]. However, the effective application of community engagement is signifi-
cantly constrained by several factors such as identifying legitimate stakeholders of interest and
determining their extent of involvement [12]. Making use of well-established programs with a
satisfactory level of community engagement can enhance the acceptance of new interventions
such as the malaria vaccine [9]. The already existing expanded program of immunization, for
example, was found to be effective in increasing the community response to the newly intro-
duced intermittent preventive treatment of malaria for infants in Mozambique [22]. Using rec-
ognized government-sponsored health information channels and community leaders as
reliable information relay points has been proposed as a means to improve community
engagement [8]. Also, minimizing barriers to understanding by translating and communicat-
ing available information in local languages have been reported as being effective in improving
community engagement and vaccine acceptance [13].
Fears associated with vaccine side effects remain a significant barrier to the acceptance of
the malaria vaccine [8–11,14]. Vaccination has previously been associated with the transmis-
sion of other diseases, as was observed in northern Nigeria with the polio vaccine [23]. Based
on the health belief model, the benefits of the malaria vaccine could be poorly perceived
because of concerns over its side effects. This could have a negative impact on the effectiveness
of the malaria vaccination program. Information relayed to communities should therefore
emphasize on the safety of the malaria vaccine. The implementation of post-vaccination sup-
port services to deal with all cases of adverse effects should also be considered.
Table 4. Proposed solutions identified from eligible studies.
Solutions Authors (publication year)
Inadequate community engagement
1. Using trusted sources for delivering health information,
2. Involving stakeholders in planning and implementation at all
levels
3. Translating information into local languages
4. Involving local leadership in the design of communication
messages
5. Using communication strategies to clarify questions and
expectations of stakeholders prior to or parallel with the
introduction of the vaccine
6. Targeting specific segments of child caregivers with relevant
messages
Bingham (2012) [8], Meñaca (2014) [9],
Mtenga (2016) [14], Ojakaa (2011) [10],
Ojakaa (2014) [11], Angwenyi (2014) [12],
Febir (2013) [13]
Fear of vaccine side effects
1. Effective communication on health information about the
vaccine using dynamic communication models that engage
caregivers of children
Bingham (2012) [8], Meñaca (2014) [9],
Inefficient delivery of the child immunization services
1. Implementing the malaria vaccine alongside the package of
services already offered at welfare clinics
Meñaca (2014) [9]
Quality of overall health service at health facility
1. Providing vaccines free of charge at the clinics and alongside
other incentives such as bed nets
Ojakaa (2011) [10]
Other reasons
1. Development of cold-chain free vaccines
2. Development of “in-house” dry ice production for vaccine
storage
Afolabi (2014) [15]
https://doi.org/10.1371/journal.pone.0209744.t004
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Two closely related determinants of vaccine acceptance consistently reported in these stud-
ies were the inefficiency in the delivery of the child vaccination services and the overall quality
of the health services offered at health facilities [8–10,15]. Care-givers are more likely to take
their children to health facilities for them to be vaccinated if they are satisfied with the quality
of the services offered at these health facilities [10,11]. Thus, improvements in the quality of
services offered at health facilities including vaccination services appear to be fundamental to
boosting vaccine acceptance.
A limited number of people have access to quality healthcare services in SSA due to the
high proportion of people living below the poverty threshold. Making vaccination free of
charge, and even using incentives to boost attendance of vaccination sessions have been
observed in some instances [10]. However, the sustainability of such methods remains ques-
tionable. Nevertheless, cost-independent factors that negatively affect hospital attendance and
access to vaccination are also likely to be encountered. An example of this, as reported by
Meñaca et al in a study conducted in Ghana, is the observed reduction in hospital attendance
of women and their children after the age of 9 months due to their perceived completion of the
vaccination calendar [9]. The possibility of a similar trend in other sub-Saharan African coun-
tries should be considered and addressed.
The partiality of the protection conferred by the RTS, S/AS01 malaria vaccine and the wan-
ing of this protective efficacy over months after vaccination were reported as potential barriers
to vaccine acceptance in a single study [11]. In contrast, these were not found to negatively
affect the vaccine acceptance in 4 studies in which the communities perceived the vaccine as a
complement rather than a substitute to the other malaria prevention measures [8–10,14].
Ensuring communities have the right perception about the role of vaccines is therefore impor-
tant for adequate vaccine acceptance.
Religious and socio-cultural factors were noted to affect the receptivity of the vaccine to dif-
ferent extents across the studies. Febir et al in West Africa (Ghana) identified no religious
beliefs or socio-cultural practices that negatively affected the acceptance of the malaria vaccine
and went on to suggest the possibility of using religious leaders to easily introduce the malaria
vaccine [13]. On the other hand Mtenga et al in East Africa (Tanzania) reported a variable
acceptance of vaccination across various religious denominations, with a greater receptivity
among Christians compared to Muslims [14].
It is worth noting that despite all these mentioned barriers to the uptake of the malaria vac-
cine, all six studies that reported on vaccine acceptance found an overall positive acceptance of
the vaccine among participants. The interpretation of the findings of this review should take
into consideration some limitations. Only studies published in English were included in the
review and this could have potentially led to some selection bias. Also, the endemicity of
malaria, and the socio-cultural and economic contexts vary widely across the continent. The
findings of this study might therefore not be generalizable to the entire continent. Neverthe-
less, the results of this study highlight important considerations for the planned RTS, S/AS01
vaccine implementation in the selected 3 countries: Ghana, Kenya, and Malawi. Five of the
studies included in this review are from two of these countries (Ghana and Kenya), and two of
the studies are from countries (Tanzania and Mozambique) sharing borders with Malawi. This
potentially approximates the findings of this review to the realities expected to be encountered
on the field during the implementation of the malaria vaccine in these countries.
Conclusion
The precise challenges in implementing a malaria vaccine in randomized trial conditions vary
from one community to another and are determined by several factors including the socio-
Challenges and solutions to the effective implementation of the RTS, S/AS01 malaria vaccine
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cultural context specific to that community. However, some common factors were seen across
the 8 populations from the five countries included in this review. Overall, vaccine acceptance
and uptake can be significantly enhanced if caregivers’ perceptions about vaccines and their
importance is adequately fine-tuned. This can be achieved through adequate community par-
ticipation and by providing information in an acceptable form via reliable communication
channels.
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